Advanz Pharma has emerged as a global frontrunner in the pharmaceutical industry, with a specific focus on specialty, hospital, and rare...

Adamis Pharmaceuticals: Pioneering a New Era in Biopharmaceuticals through Merger with DMK Pharmaceuticals On the heels of an impressive...

BioSenic, a top-notch biotech firm, and Phebra, a leading Australian pharmaceutical developer, are working together to amend their...

Sun Pharmaceutical Industries Limited, a leading global pharmaceutical company, and Philogen S.p.A, a pioneering biotechnology firm, have...

Healthcare data management is evolving rapidly with the advent of technology. One of the key players, BC Platforms (BCP), has recently...

Switzerland-based biopharmaceutical company, Idorsia Ltd (SIX: IDIA) has recently made headlines with its announcement of entering into...

Introduction In the ever-evolving domain of biotechnology and medicinal products, companies are always on the lookout for strategic moves...

Mendus AB, a trailblazer in the development of immunotherapies for cancer recurrence, has announced a ground-breaking partnership with...

Novartis AG, a global healthcare company, has announced its intention to acquire Chinook Therapeutics Inc., a clinical-stage...

ProKidney, a trailblazer in the cellular therapeutics landscape, has recently announced its plans to acquire a manufacturing facility in...

Introduction Praxis Precision Medicines, a biopharmaceutical organization at the clinical stage, has made a substantial breakthrough. The...

Prime Medicine and Cimeio Therapeutics, two renowned biotechnology companies, have announced a research collaboration. Their shared goal...

Swiss pharmaceutical firm, Santhera Pharmaceuticals (ticker symbol: SANN) recently confirmed the finalization of its exclusive licensing...

Clinical-stage company Panbela Therapeutics, Inc. (Nasdaq: PBLA) has announced it has sold certain assets within its eflornithine...

XOMA Corporation, a renowned player in the biotechnology industry, has recently expanded its asset collection. The company has announced...

FDA's traditional approval of LEQEMBI® (lecanemab-irmb) heralds a new era for Alzheimer's disease (AD) treatment. The drug has...

Burjeel Holdings, a renowned healthcare provider in the MENA region, and BridgeBio Pharma, Inc., a company with a strong focus on genetic...

LifeArc, a self-funded medical research organisation, and DEBRA Austria, a patient organisation charity, have recently initiated an...

Tonix Pharmaceuticals, a clinical-stage biopharmaceutical firm, has been at the forefront of breakthrough medical advancements,...

F-star Therapeutics, an invoX company, has announced a strategic collaboration and license agreement with Takeda to develop...